← back to search

Giovanni Battista Vigna

University of Ferrara · IT
Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Internal medicine, Cholesterol, Familial hypercholesterolemia, Disease, and Endocrinology.
h-index
citations
1,325
works
24
NIH funding
primary concept
email

Recent publications

Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case–control study
Scientific Reports 2023cited by 4position: middledoi
Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations
Journal of clinical lipidology 2022cited by 4position: firstdoi
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
Orphanet Journal of Rare Diseases 2021cited by 31position: middledoi
Successful fenofibrate therapy for severe and persistent hypertriglyceridemia in a boy with cirrhosis and glycerol‐3‐phosphate dehydrogenase 1 deficiency
JIMD Reports 2020cited by 16position: middledoi
Cardiovascular events, LDL and HDL subfraction size in a cohort of FH patients
Atherosclerosis 2020cited by 0position: lastdoi
Association between size of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol particles and cardiovascular events in type 2 diabetes subjects
Atherosclerosis 2020cited by 0position: middledoi
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
Atherosclerosis 2019cited by 35position: middledoi
Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease
Gerontology 2018cited by 41position: middledoi
Reduced incidence of cardiovascular events in hyper-Lp(a) patients on lipoprotein apheresis. The G.I.L.A. (Gruppo Interdisciplinare Aferesi Lipoproteica) pilot study
Transfusion and Apheresis Science 2018cited by 27position: middledoi
Distribution of Paraoxonase‐1 (PON‐1) and Lipoprotein Phospholipase A2 (Lp‐PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
Oxidative Medicine and Cellular Longevity 2018cited by 20position: middledoi
Combining LDL-C and HDL-C to predict survival in late life: The InChianti study
PLoS ONE 2017cited by 20position: middledoi
Ultrasound evaluation of Achilles tendon in diagnosis of Familial Hypercholesterolemia: A case-control study
Nutrition Metabolism and Cardiovascular Diseases 2017cited by 0position: lastdoi
Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature
BMC Neurology 2016cited by 55position: middledoi
Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
BBA Clinical 2015cited by 61position: middledoi
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial
Atherosclerosis 2015cited by 45position: middledoi
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort
Nutrition Metabolism and Cardiovascular Diseases 2015cited by 20position: lastdoi
Abstract 12450: Long-Term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial
Circulation 2015cited by 4position: middledoi
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia
Nutrition Metabolism and Cardiovascular Diseases 2014cited by 30position: firstdoi
ANGPTL3, carotid imt and advanced lipid profiling in dyslipidemias: Data from the adsl project
Atherosclerosis 2014cited by 0position: middledoi
Evaluation of serum cholesterol efflux capacity in diabetic compared to healthy subjects
Atherosclerosis 2014cited by 0position: middledoi
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
The Lancet 2012cited by 736position: middledoi
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia
Arteriosclerosis Thrombosis and Vascular Biology 2012cited by 82position: middledoi
Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
Acta Diabetologica 2012cited by 63position: middledoi
Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study
Atherosclerosis 2012cited by 31position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Giovanni Zuliani · University of Ferrara9 papers (2012–2023)Angelina Passaro · University of Ferrara8 papers (2015–2023)Maurizio Averna · European Atherosclerosis Society6 papers (2012–2015)Cristina Bosi · University of Ferrara5 papers (2012–2020) · 4 papers (2014–2019) · 4 papers (2014–2023)Edoardo Dalla Nora · University of Ferrara4 papers (2019–2023)Mario Luca Morieri · Zuyderland Medisch Centrum4 papers (2012–2019)Stefano Volpato · University of Ferrara4 papers (2012–2017)Claudia Stefanutti · Amgen (United States)4 papers (2012–2015)Juana María Sanz · University of Ferrara4 papers (2014–2023)Emma A. Meagher · Translational Therapeutics (United States)3 papers (2012–2015)Marina Cuchel · World Heart Federation3 papers (2012–2015)Angelo B. Cefalù · University of Ferrara3 papers (2012–2015) · 3 papers (2014–2014)Daniel J. Rader · RWTH Aachen University3 papers (2012–2015)LeAnne T. Bloedon · Esperion Therapeutics (United States)3 papers (2012–2015)Dirk Blom · South African Medical Research Council3 papers (2012–2015)Daniel Gaudet · Thrombolysis in Myocardial Infarction Study Group3 papers (2012–2015) · 3 papers (2012–2015)